Technical Articles

This article systematically elaborates on the central role of kinases as anticancer drug targets and the structural characteristics of their catalytic domains, focusing on screening strategies and design methods for protein kinase inhibitors. It analyzes the critical role of structure-based molecular design in kinase inhibitor development and explores the differentiated design strategies for Type I, Type II, and Type III kinase inhibitors.